Mutational processes molding the genomes of 21 breast cancers.
Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, Menzies A, Martin S, Leung K, Chen L, Leroy C, Ramakrishna M, Rance R, Lau KW, Mudie LJ, Varela I, McBride DJ, Bignell GR, Cooke SL, Shlien A, Gamble J, Whitmore I, Maddison M, Tarpey PS, Davies HR, Papaemmanuil E, Stephens PJ, McLaren S, Butler AP, Teague JW, Jönsson G, Garber JE, Silver D, Miron P, Fatima A, Boyault S, Langerød A, Tutt A, Martens JW, Aparicio SA, Borg Å, Salomon AV, Thomas G, Børresen-Dale AL, Richardson AL, Neuberger MS, Futreal PA, Campbell PJ, Stratton MR, Breast Cancer Working Group of the International Cancer Genome Consortium. · 2012
Read Mutational processes molding the genomes of 21 breast cancers. by Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, Menzies A, Martin S, Leung K, Chen L, Leroy C, Ramakrishna M, Rance R, Lau KW, Mudie LJ, Varela I, McBride DJ, Bignell GR, Cooke SL, Shlien A, Gamble J, Whitmore I, Maddison M, Tarpey PS, Davies HR, Papaemmanuil E, Stephens PJ, McLaren S, Butler AP, Teague JW, Jönsson G, Garber JE, Silver D, Miron P, Fatima A, Boyault S, Langerød A, Tutt A, Martens JW, Aparicio SA, Borg Å, Salomon AV, Thomas G, Børresen-Dale AL, Richardson AL, Neuberger MS, Futreal PA, Campbell PJ, Stratton MR, Breast Cancer Working Group of the International Cancer Genome Consortium. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3414841.txt.
Introduction
Nik-Zainal led a team that catalogued every mutation in twenty-one breast cancers in 2012 to read the processes that scarred their genomes. All cancers carry acquired mutations, and their patterns record the damage and repair failures the cells lived through. Math methods pulled apart the overlapping patterns into separate signatures.
Several distinct signatures appeared, some single-letter and some double. Cancers with broken BRCA1 or BRCA2 genes showed a characteristic mix plus a telltale pattern of deletions. The team also found kataegis, storms of local hypermutation clustered near genome rearrangements. A family of enzymes that edit DNA letters is proposed as one culprit. Most signatures still lack an explanation, marking work ahead.
Catalog record
| CREATOR | Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, Menzies A, Martin S, Leung K, Chen L, Leroy C, Ramakrishna M, Rance R, Lau KW, Mudie LJ, Varela I, McBride DJ, Bignell GR, Cooke SL, Shlien A, Gamble J, Whitmore I, Maddison M, Tarpey PS, Davies HR, Papaemmanuil E, Stephens PJ, McLaren S, Butler AP, Teague JW, Jönsson G, Garber JE, Silver D, Miron P, Fatima A, Boyault S, Langerød A, Tutt A, Martens JW, Aparicio SA, Borg Å, Salomon AV, Thomas G, Børresen-Dale AL, Richardson AL, Neuberger MS, Futreal PA, Campbell PJ, Stratton MR, Breast Cancer Working Group of the International Cancer Genome Consortium. |
|---|---|
| YEAR | 2012 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Mutational Processes Molding the Genomes of 21 Breast Cancers By Serena Nik-Zainal, Ludmil B. Alexandrov, David C. Wedge, Peter Van Loo, Christopher D. Greenman, Keiran Raine, David Jones, Jonathan Hinton, John Marshall, Lucy A. Stebbings, Andrew Menzies, Sancha Martin Published in: Cell DOI: 10.1016/j.cell.2012.04.024 ABSTRACT Summary All cancers carry somatic mutations. The patterns of mutation in cancer genomes reflect the DNA damage and repair processes to which cancer cells and their precursors have been exposed. To explore these mechanisms further, we generated catalogs of somatic mutation from 21 breast cancers and applied mathematical methods to extract mutational signatures of the underlying processes. Multiple distinct single- and double-nucleotide substitution signatures were discernible. Cancers with BRCA1 or BRCA2 mutations exhibited a characteristic combination of substitution mutation signatures and a distinctive profile of deletions. Complex relationships between somatic mutation prevalence and transcription were detected. A remarkable phenomenon of localized hypermutation, termed “kataegis,” was observed. Regions of kataegis differed between cancers but usually colocalized with somatic rearrangements. Base substitutions in these regions were almost exclusively of cytosine at TpC dinucleotides. The mechanisms underlying most of these mutational signatures are unknown. However, a role for the APOBEC family of cytidine deaminases is proposed. PaperClip INTRODUCTION Cancers carry somatic mutations. A small proportion are “drivers” that confer clonal advantage, are causally implicated in oncogenesis, and have been positively selected during the evolution of the cancer (Stratton, 2011; Stratton et al., 2009). Driver mutations occur in the subset of genes known as cancer genes. Through systematic sequencing of cancer genomes, considerable advances have recently been made in the identification of cancer genes, providing insights into mechanisms of neoplastic transformation and targets for therapeutic intervention (Stratton, 2011; Stratton et al., 2009). We have relatively limited understanding, however, of the DNA damage and repair processes that have been operative during the lifetime of the patient and that are responsible for the somatic mutations that underlie the development of all cancers in the first place. Historically, analysis of mutation patterns to investigate underlying DNA damage and repair processes in human cancers has predominantly been restricted to reporter cancer genes, notably TP53. These studies have revealed that mutation patterns can be related to carcinogen exposures and DNA repair processes. For example, G>T/C>A transversions predominate in smoking-associated lung cancer, a pattern compatible with DNA damage induced by tobacco carcinogens such as benzo[a]pyrene diolepoxide (Pfeifer et al., 2002). These mutations are enriched at CpG dinucleotides and exhibit a transcriptional strand bias reflecting past activity of transcription-coupled nucleotide excision repair (TCR) on bulky adducts of guanine caused by tobacco carcinogens (Hainaut and Pfeifer, 2001). Similarly, in UV-light-associated skin cancers, C>T and CC>TT transitions are common. These occur at dipyrimidines, reflecting the formation of pyrimidine dimers following exposure of DNA to UV light (Pfeifer et al., 2005) and also show transcriptional strand bias due to the action of TCR on pyrimidine dimers. Further examples of exogenous exposures leading to distinctive mutational patterns include G>T transversions in aflatoxin B1-associated hepatocellular carcinomas (Macé et al., 1997) and A>T transversions in urothelial tumors from patients exposed to aristolochic acid (Nedelko et al., 2009). Although these studies have been highly informative, they have limitations. Because they depend upon driver mutations, effects of selection have been superimposed upon mutational patterns generated by DNA damage and repair processes. Moreover, only a single mutation from each cancer sample is usually incorporated into each data set. Thus, they have been well placed to report strong exposures and dominant repair processes operative across most cases of a particular tumor type. However, where there is heterogeneity of mutational process in a cancer class, a composite of different processes will be reported. The completion of the human genome sequence and the advent of second-generation sequencing technology have overcome historic limitations of scale, permitting sequencing of whole cancer genomes (Berger et al., 2011; Chapman et al., 2011; Ding et al., 2010; Lee et al., 2010; Ley et al., 2008; Mardis et al., 2009; Shah et al., 2009; Tao et al., 2011), and generation of comprehensive catalogs of somatic mutation (Pleasance et al., 2010a; Pleasance et al., 2010b). Most somatic mutations in cancers are thought to be “passenger” events that do not contribute to cancer development. These bystanders bear the imprints of the DNA damage and repair processes operative during the development of the cancer, unmodified by selection. The several hundreds to tens of thousands of somatic mutations in each cancer, therefore, potentially allow much greater resolution of mutational patterns and insights into underlying mutational processes. Recent analyses of comprehensive mutational catalogs from a malignant melanoma and a lung cancer illustrate the power of this approach (Pleasance et al., 2010a; Pleasance et al., 2010b). They revealed the characteristic mutational patterns of UV light and tobacco carcinogens respectively (see above) and provided strong evidence for the past activity of TCR. In addition, G>T mutations in the lung cancer showed a preference for CpG dinucleotides outside CpG islands, suggesting a role for methylated cytosine because CpG islands are usually unmethylated. Conversely, G>C mutations at CpG dinucleotides were more prevalent within CpG islands suggesting that the mutagen(s) underlying these mutations preferentially acted on unmethylated DNA (Pleasance et al., 2010b). In the melanoma, at least one additional mutational process characterized by G>T changes and independent of UV light exposure was shown to have been operative. In both cancers, mutations were more common in poorly expressed than in highly expressed genes, both on the transcribed and untranscribed strands. Indeed, mutations were also found to be more prevalent at the 3′ ends of genes than at the 5′ ends (Pleasance et al., 2010a). The mechanisms underlying these expression-related phenomena are unknown. Compared to melanoma and lung cancer, the mutational processes underlying other cancer types are poorly understood. Therefore, in this study, we document essentially the full repertoire of somatic mutations of 21 breast cancers to investigate the mutational mechanisms shaping these cancer genomes. RESULTS Sequencing of Breast Cancers We sequenced the complete genomes of 21 primary breast cancers and matched normal DNAs from the same individuals. Cancers were typed for estrogen receptors (ER), progesterone receptors (PR), and HER2, and included nine cases with germline mutations in the breast cancer predisposition genes BRCA1 (five) and BRCA2 (four) (Table S1A, available online). Cancer and normal DNAs were sequenced to > 30-fold coverage and analyzed to identify somatic base substitutions, insertions, and deletions (indels); rearrangements; and copy number changes. PD4120a was sequenced to ∼188-fold depth to investigate temporal and clonal evolution (Nik-Zainal et al., 2012). Using orthogonal sequencing technologies we estimated the specificity of substitution-calling to be ∼92.1% (Table S1A). All substitutions were therefore included in the analyses. For indels and rearrangements only confirmed variants were included (Table S1B). From 17 of the 21 cases mRNA expression data were also obtained. The Catalogue of Somatic Mutations from 21 Breast Cancer Genomes A total of 183,916 somatically acquired base substitutions were identified (see Table S1B for hyperlinks). In protein coding regions, there were 1,372 missense, 117 nonsense, 2 stop-lost, 37 essential splice-site, and 521 silent mutations. Of the 2,869 indels identified, 2,233 were deletions, 544 insertions and 92 complex. There were 21 coding indels, of which 15 were predicted to result in a translational frameshift and six were